Skip to content

Study of the effect of flurbiprofen for prevention of mesenteric traction syndrome.

Study of the effect of flurbiprofen for prevention of mesenteric traction syndrome. - MTS trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000009111
Enrollment
60
Registered
2012-10-14
Start date
2011-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mesenteric traction syndrome (colorectal cancer)

Interventions

Administration of flurbiprofen axetil during induction of anesthesia Administration of flurbiprofen axetil after the onset of mesenteric traction syndrome. No preventive action

Sponsors

Tokyo Metropolitan Bokutoh Hospital
Lead Sponsor
Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Elected abdominal colorectal surgery patients in our hospital

Exclusion criteria

Exclusion criteria: Liver dysfunction Renal dysfunction Gastroduodenal ulcer Aspirin-induced asthma Laparoscopic surgery

Design outcomes

Primary

MeasureTime frame
The incidence of mesenteric traction syndrome

Countries

Japan

Contacts

Public ContactHidemasa takahashi

Tokyo Metropolitan Bokutoh Hospital Dept. anesthesiology

03-3633-6151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026